Aviva accelerates profit targets, doubles cost cutting at Direct Line

Aviva PLC announced it anticipates achieving its 2026 financial targets a year early, driven by strong performance and accelerated integration of Direct Line operations. The insurer set new ambitious 2028 targets, including an 11% compound annual growth in operating EPS, a return on equity exceeding 20%, and over £7 billion in cumulative cash remittances. Cost synergies from the Direct Line acquisition have been increased to £225 million by 2028, alongside £500 million in capital synergies, contributing to a projected 2025 operating profit of £2.2 billion, with the company also planning to resume higher share buybacks next year.

Analysis

Aviva PLC announced it anticipates achieving its 2026 financial targets a year early, driven by robust performance and accelerated integration of Direct Line operations. The company reported a 12% growth in general insurance premiums to £10 billion for Q3 2025, contributing to an expected 2025 group operating profit of £2.2 billion, including £150 million from Direct Line. This strong operational execution underpins the revised outlook.

The FTSE 100 insurer introduced ambitious new targets for 2028, projecting an 11% compound annual growth rate in operating EPS and a return on equity exceeding 20%. Furthermore, Aviva expects over £7 billion in cumulative cash remittances between 2026 and 2028, alongside a strategic shift towards capital-light business, which is projected to comprise over 75% of its operations by 2028. These targets signal confidence in future profitability and capital efficiency.

Cost synergies from the Direct Line acquisition have been significantly increased, with the new target set at £225 million by 2028, up from £100 million, in addition to unlocking at least £500 million in capital synergies. This enhanced synergy capture, coupled with the planned resumption of higher share buybacks next year, indicates a strong focus on shareholder returns and efficient capital deployment. The accelerated synergy realization and capital return plans are likely to be viewed positively by the market.

Key Decisions for Investors

• Investors should assess Aviva's revised 2028 targets, including 11% EPS CAGR and >20% ROE, as indicators of sustained profitability and operational efficiency.
• Monitor the successful realization of the increased £225 million Direct Line cost synergies and £500 million capital synergies, which are crucial for enhanced shareholder value.
• Consider the impact of the planned resumption of higher share buybacks on capital returns and the company's commitment to shareholder distribution.